wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33265964-515CAFAB-BB3E-4214-B589-2C4E2AE0B822
Q33265964-515CAFAB-BB3E-4214-B589-2C4E2AE0B822
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33265964-515CAFAB-BB3E-4214-B589-2C4E2AE0B822
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
P2860
Q33265964-515CAFAB-BB3E-4214-B589-2C4E2AE0B822
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33265964-515CAFAB-BB3E-4214-B589-2C4E2AE0B822
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3bff2a511fe833b5192c6d575e37327a46fee9ad
P2860
Newer approaches to gemcitabine-based therapy of pancreatic cancer: fixed-dose-rate infusion and novel agents.